Haleon (HLN) Long-Term Debt Issuances (2021 - 2025)
Haleon's (HLN) quarterly Long-Term Debt Issuances came in at $53.6 million in Q4 2025, down 72.32% on a QoQ basis from $193.6 million in Q4 2023.
Haleon (HLN) Long-Term Debt Issuances (2021 - 2025) Analysis & Trends
Haleon (HLN) has 4 years of Long-Term Debt Issuances data on file, last reported at $53.6 million in Q4 2025.
- Quarterly Long-Term Debt Issuances changed N/A year-over-year to $53.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $22.5 billion (changed N/A YoY) and the FY2025 annual result came in at $61.2 million, down 96.06% from the prior year.
- Long-Term Debt Issuances eased to $53.6 million in Q4 2025, from $193.6 million in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $11.4 billion in Q3 2022 to a low of $1.3 million in Q4 2021.
- A 4-year average of $4.5 billion and a median of $193.6 million in 2023 frame the typical range for Long-Term Debt Issuances.
- Annual changes were most pronounced in 2022 — Long-Term Debt Issuances jumped 803976.06% — and 2023, when it sank 98.21%.
- Tracing HLN's Long-Term Debt Issuances over 4 years: stood at $1.3 million in 2021, then surged by 803976.06% to $10.8 billion in 2022, then slumped by 98.21% to $193.6 million in 2023, then tumbled by 72.32% to $53.6 million in 2025.
- The last three Long-Term Debt Issuances figures came in at $53.6 million (Q4 2025), $193.6 million (Q4 2023), and $10.8 billion (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.31 Bn | 39.66 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.65 Bn | 29.98 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.18 Bn | 19.52 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.82 Bn | 17.94 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 53.59 Mn |
| Dec 31, 2025 | 53.59 Mn |
| Dec 31, 2023 | 193.62 Mn |
| Dec 31, 2023 | 193.62 Mn |
| Dec 31, 2022 | 10.84 Bn |
| Dec 31, 2022 | 10.84 Bn |
| Sep 20, 2022 | 11.38 Bn |
| Sep 20, 2022 | 11.38 Bn |
| Dec 31, 2021 | 1.35 Mn |
| Dec 31, 2021 | 1.35 Mn |